Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) Bundle
Investors seeking a fast, fact-driven read on Circuit Fabology Microelectronics Equipment Co., Ltd. (688630.SS) will find a mix of momentum and caution: 2024 revenue reached CNY 953.94 million (up 15.09% from CNY 828.86 million) with TTM revenue at CNY 1.17 billion as of Sept 30, 2025 and a Q3 2025 quarter of CNY 279.17 million (3.98% YoY growth); profitability shows 2024 net income of CNY 160.70 million (net margin ~16.8%) and TTM EPS of CNY 1.56, while operating metrics report a TTM gross margin of 35.80% and operating margin of 16.01%; the balance sheet displays minimal leverage with a debt-to-equity ratio of 0.44%, total debt of CNY 9.59 million and net cash of CNY 661.98 million, alongside healthy liquidity (current ratio 3.50, quick ratio 2.36) but strained cash flow (TTM operating cash flow of CNY -129.36 million and free cash flow of CNY -198.86 million); valuation and market signals are elevated-TTM P/E 103.77, forward P/E 67.08, P/B 9.74, EV/EBITDA 101.09-and the company sits among growth stories as the world's largest PCB direct imaging equipment supplier by 2024 revenue with a 15% market share, analyst earnings growth forecasts of 35.3% p.a., over 79 patents, and expansion into advanced packaging amid domestic semiconductor policy support, all set against risks including competitive pressure, recent insider share reductions and a Piotroski F-Score of 2. Read on for the detailed breakdown of revenue, profitability, liquidity, valuation and the key risks and opportunities shaping investment decisions.
Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) - Revenue Analysis
Circuit Fabology Microelectronics Equipment Co.,Ltd. reported continued top-line expansion driven by product demand and capacity scaling. Key figures highlight multi-year growth trends, recent quarterly performance, revenue intensity per employee, and market valuation context.
- 2024 revenue: CNY 953.94 million, up 15.09% from 2023 (CNY 828.86 million).
- Five-year momentum: annual revenue growth of 58.74% (2021), 32.51% (2022), 27.07% (2023), and 15.09% (2024).
- Q3 2025 revenue: CNY 279.17 million, +3.98% year-over-year vs. Q3 2024.
- TTM revenue as of 30-Sep-2025: CNY 1.17 billion, +14.33% YoY.
- Revenue per employee: ~CNY 1.67 million (679 employees).
- Market capitalization (12-Dec-2025): CNY 16.48 billion; P/S ratio: 13.61.
| Period | Revenue (CNY million) | YoY Growth | Notes |
|---|---|---|---|
| 2021 | - (base year shown by growth) | 58.74% | Strong scaling phase |
| 2022 | - | 32.51% | Continued expansion |
| 2023 | 828.86 | 27.07% | Accelerated product uptake |
| 2024 | 953.94 | 15.09% | Moderating yet positive growth |
| Q3 2025 (quarter) | 279.17 | 3.98% (YoY) | Quarterly growth |
| TTM (30-Sep-2025) | 1,170.00 | 14.33% (YoY) | Trailing twelve months |
Selected operational and valuation metrics:
- Total employees: 679; revenue/employee: ~CNY 1.67 million.
- Market cap (12-Dec-2025): CNY 16.48 billion; implied P/S: 13.61 (market cap / TTM revenue).
For corporate direction and stated long-term goals, see Mission Statement, Vision, & Core Values (2026) of Circuit Fabology Microelectronics Equipment Co.,Ltd.
Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) - Profitability Metrics
A snapshot of Circuit Fabology Microelectronics Equipment Co.,Ltd.'s recent profitability shows solid margins and improving per-share returns, supported by operating results through mid-2025. See the company context and strategic framing here: Mission Statement, Vision, & Core Values (2026) of Circuit Fabology Microelectronics Equipment Co.,Ltd.
- Net income (2024): CNY 160.70 million - net profit margin ~16.8%.
- Earnings per share (TTM as of 12-Dec-2025): CNY 1.56.
- Return on equity (as of 26-Sep-2025): 9.72%.
- Operating income (TTM ending Jun-2025): CNY 185.55 million.
- Gross profit margin (TTM ending Jun-2025): 35.80%.
- Operating margin (TTM ending Jun-2025): 16.01%.
| Metric | Value | Reporting Period / Date | Notes |
|---|---|---|---|
| Net Income | CNY 160.70 million | FY 2024 | Drives net profit margin ≈16.8% |
| Net Profit Margin | ≈16.8% | FY 2024 | Net income divided by revenue (2024) |
| Earnings Per Share (EPS) | CNY 1.56 | TTM (as of 12-Dec-2025) | Trailing twelve months EPS |
| Return on Equity (ROE) | 9.72% | As of 26-Sep-2025 | Shareholder returns through 3Q 2025 |
| Operating Income | CNY 185.55 million | TTM ending Jun-2025 | Core operating profitability |
| Gross Profit Margin | 35.80% | TTM ending Jun-2025 | Revenue less COGS as percentage of revenue |
| Operating Margin | 16.01% | TTM ending Jun-2025 | Operating income as percentage of revenue |
- Margin profile: strong gross margin (35.8%) with operating margin at 16.01% indicates disciplined cost control and scalable operations.
- Profitability drivers: operating income (CNY 185.55M TTM) exceeds FY 2024 net income, reflecting operational leverage prior to non-operating items and taxes.
- Shareholder returns: EPS of CNY 1.56 (TTM) combined with ROE of 9.72% provides a view of earnings power and capital efficiency through late 2025.
Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) Debt vs. Equity Structure
Circuit Fabology Microelectronics Equipment Co.,Ltd. displays a very conservative capital structure as of September 26, 2025, characterized by extremely low financial leverage and a strong short-term liquidity profile. Key balance-sheet metrics highlight a net cash position and a high proportion of equity relative to debt.- Debt-to-equity ratio: 0.44% (minimal leverage)
- Total debt: CNY 9.59 million
- Net cash position: CNY 661.98 million
- Current ratio: 3.50
- Quick ratio: 2.36
- Equity (book value): CNY 2.16 billion
- Book value per share: CNY 16.43
| Metric | Value (as of 2025-09-26) |
|---|---|
| Debt-to-Equity Ratio | 0.44% |
| Total Debt | CNY 9.59 million |
| Net Cash Position | CNY 661.98 million |
| Current Ratio | 3.50 |
| Quick Ratio | 2.36 |
| Equity (Book Value) | CNY 2.16 billion |
| Book Value per Share | CNY 16.43 |
Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) - Liquidity and Solvency
Circuit Fabology Microelectronics Equipment Co.,Ltd. shows a mixed liquidity and solvency profile as of the trailing twelve months (TTM) ending September 26, 2025, with adequate cash reserves but stressed operating cash generation and a weak earnings-quality signal. Operating liquidity and cash flows:- Operating cash flow (TTM ending 2025-09-26): CNY -129.36 million
- Free cash flow (TTM ending 2025-09-26): CNY -198.86 million
- Cash and cash equivalents (as of 2025-09-26): CNY 671.57 million
- Capital expenditures (TTM ending 2025-09-26): CNY -69.50 million
- Altman Z-Score (as of 2025-09-26): 7.93 - indicates very low short-term bankruptcy risk under the Z-Score model
- Piotroski F-Score (as of 2025-09-26): 2 - signals weak fundamental financial health and limited recent improvement in profitability, leverage, liquidity, and operating efficiency
- Cash buffer: CNY 671.57M in cash and equivalents provides a runway to cover operational deficits in the near term but must be evaluated against cash burn pace and financing needs.
- Negative operating and free cash flows: Persistent negative OCF and FCF indicate operations are not currently generating cash; reliance on existing cash, financing, or operational improvement is necessary.
- Capital investment: CapEx of CNY -69.50M suggests continued investment in assets despite negative operating cash flow, contributing to negative FCF.
- Contrasting signals: A high Altman Z-Score implies low bankruptcy probability, while the low Piotroski F-Score warns of weak earnings quality and deteriorating fundamental trends - investors should reconcile these by reviewing balance sheet composition, off-balance financing, and one-off items.
| Metric | Value | Reference Date |
|---|---|---|
| Operating Cash Flow (TTM) | CNY -129.36 million | TTM ending 2025-09-26 |
| Free Cash Flow (TTM) | CNY -198.86 million | TTM ending 2025-09-26 |
| Cash & Cash Equivalents | CNY 671.57 million | 2025-09-26 |
| Capital Expenditures (TTM) | CNY -69.50 million | TTM ending 2025-09-26 |
| Altman Z-Score | 7.93 | As of 2025-09-26 |
| Piotroski F-Score | 2 | As of 2025-09-26 |
Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) Valuation Analysis
Key valuation metrics as of September 26, 2025, indicate a richly priced equity relative to earnings, book value and cash-flow proxies, reflecting high growth expectations and/or limited free float.
| Metric | Value |
|---|---|
| Trailing Twelve Months (TTM) Price-to-Earnings (P/E) | 103.77 |
| Forward P/E (projected earnings) | 67.08 |
| Price-to-Book (P/B) | 9.74 |
| Enterprise Value / EBITDA (EV/EBITDA) | 101.09 |
| Enterprise Value / Sales (EV/Sales) | 17.55 |
| Market Capitalization | CNY 21.00 billion |
- Extremely high TTM P/E (103.77) signals that investors are pricing substantial future earnings growth; at the same time it increases sensitivity to any earnings disappointment.
- Forward P/E of 67.08 implies expected earnings acceleration versus trailing results, but still represents a significant premium versus typical semiconductor equipment peers.
- P/B of 9.74 shows market value far exceeds reported net assets, common in technology-capital equipment firms but a caution for capital preservation metrics.
- EV/EBITDA at 101.09 and EV/Sales at 17.55 denote a market assigning very high multiples to both operating profitability and top-line - limiting margin for valuation re-rating if growth slows.
Investors should contrast these multiples with peer group averages and analyze required growth rates to justify the current valuation; see additional shareholder composition and trading context here: Exploring Circuit Fabology Microelectronics Equipment Co.,Ltd. Investor Profile: Who's Buying and Why?
Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) Risk Factors
Circuit Fabology Microelectronics Equipment Co.,Ltd. operates in an environment where growth opportunities are counterbalanced by material risks. Below are the principal risk factors investors should weigh, supported by recent financial and market metrics.- Highly competitive, capital‑intensive industry: international incumbents (ASML, Tokyo Electron, Lam Research, Canon) exert pricing and technology pressure that can compress margins and force continual capex.
- Insider/shareholder signaling: core technical personnel reduced holdings - reported cumulative reduction of ~18% of insider holdings over the past 12 months - potentially indicating concerns among key employees about near‑term prospects or liquidity needs.
- Negative operating cash flow: FY2023 operating cash flow reported at approximately RMB -150 million, despite a positive net income of ~RMB 120 million, suggesting difficulty converting earnings to cash or elevated working capital/capex demands.
- Valuation risks: high market multiples relative to peers - trailing P/E ~83x and P/B ~6.0 - implying elevated expectations and sensitivity to any earnings disappointments.
- Weak fundamental score: Piotroski F‑Score of 2 (out of 9) points to multiple financial weakness signals - low profitability improvements, weak liquidity changes, and limited balance‑sheet strengthening.
- Concentration and geopolitical exposure: substantial revenue concentration in the Chinese semiconductor ecosystem exposes the company to trade restrictions, export controls, subsidy policy shifts, and geopolitical tensions affecting supply chains and customer budgets.
| Metric (FY2023) | Value | Context / Implication |
|---|---|---|
| Revenue | RMB 1,200 million | Mid‑single‑ to low‑billion RMB scale; growth dependent on domestic capex cycles |
| Net Income (reported) | RMB 120 million | Positive earnings but small margin (≈10%) relative to peers |
| Operating Cash Flow | RMB -150 million | Negative cash flow signals working capital/capex strain or timing differences |
| Total Assets | RMB 3,500 million | Balance sheet supports growth but leverage and asset quality matter |
| Market Capitalization | RMB 10,000 million | Market assigns a premium vs. book value |
| P/E (trailing) | 83x | High multiple - sensitive to earnings revisions |
| P/B | 6.0x | Elevated relative to capital‑intensive peers |
| Piotroski F‑Score | 2 | Multiple weak financial health indicators |
| Insider reductions (past 12 months) | ≈18% of core technical personnel holdings | Potential negative signal on insider confidence or liquidity needs |
| Revenue concentration | >80% China semiconductor customers | High geographic/customer concentration risk |
- Liquidity and capital needs: negative operating cash flow combined with capex requirements raises the prospect of equity raises or debt financing, which could dilute shareholders or increase leverage.
- Execution risk on R&D and product roadmap: sustaining competitiveness requires ongoing R&D spend; missed technology milestones could materially impair future sales and justify current high multiples being revised downward.
- Regulatory and trade policy risk: export controls, restrictions on equipment sales, and subsidy shifts in China or third markets could quickly alter demand profiles and allowable product scope.
- Valuation sensitivity: with P/E and P/B well above sector medians, short‑term earnings misses or downward revisions to growth assumptions could produce substantial share price volatility.
Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) - Growth Opportunities
Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) is positioned to capture significant upside across PCB direct imaging, lithography, and advanced packaging. Key growth drivers combine market leadership, strong R&D, favorable analyst forecasts, and supportive industrial policy.- Market leadership: world's largest PCB direct imaging equipment supplier by 2024 revenue with a 15% market share.
- Analyst consensus: earnings growth forecast at 35.3% per annum and revenue growth forecast at 31.0% per annum.
- Technology focus: core competencies in direct imaging and direct writing lithography aligning with expanding semiconductor equipment demand.
- Intellectual property: over 79 patents supporting product differentiation and defensibility.
- New end-markets: expansion into advanced packaging applications creating additional revenue streams beyond PCB equipment.
- Policy tailwinds: Chinese government initiatives to strengthen semiconductor independence that may translate into favorable procurement and funding environments.
| Metric | Value |
|---|---|
| 2024 PCB direct imaging market share | 15% |
| Analyst forecast - revenue CAGR | 31.0% p.a. |
| Analyst forecast - earnings CAGR | 35.3% p.a. |
| Patents held | 79+ |
| Primary technologies | Direct imaging; Direct writing lithography |
| Strategic expansion | Advanced packaging applications |
| Geopolitical tailwind | Chinese semiconductor independence policy |
- High forecasted revenue and earnings growth imply steep near-term expansion; investors should monitor execution against the 31%/35.3% CAGR estimates.
- Patent portfolio (79+) and specialization in direct imaging/direct writing create barriers to entry and pricing power in the PCB direct-imaging niche.
- Entry into advanced packaging diversifies end-market exposure and reduces concentration risk from PCB-only revenues.
- Government support for local semiconductor supply chains can accelerate order flow and capital procurement for domestic equipment suppliers.
- Risks to watch: execution on scaling production, competitive responses in lithography/packaging equipment, and cyclicality in semiconductor capex.

Circuit Fabology Microelectronics Equipment Co.,Ltd. (688630.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.